Invasive cancer
The primary outcome of the randomised VITAL trial: 2,000 IU of vitamin D3 daily versus placebo did not reduce the incidence of invasive cancer (NEJM, 2019).
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.